Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-119241
Filing Date
2025-12-08
Accepted
2025-12-08 14:20:30
Documents
1
Period of Report
2021-08-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2528495-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2528495-1_4seq1.xml 4 3801
  Complete submission text file 0001104659-25-119241.txt   5916
Mailing Address
Business Address TWO LEDGEMONT CENTER 95 HAYDEN AVE LEXINGTON MA 02420 6174029000
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ (Reporting) CIK: 0000042872 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39532 | Film No.: 251555664
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713
Business Address 2525 EAST NORTH CAROLINA HIGHWAY 54 DURHAM NC 27713 919-313-9633
Humacyte, Inc. (Issuer) CIK: 0001818382 (see all company filings)

EIN.: 851763759 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)